MRDR Events at Blood 2025

Come and see the presentations using MRDR data, and visit us at the Monash University booth in the Exhibition Hall - Booth 119. Please pop by if you have any questions about the registry or to say hi!

Presenter Project Oral / Poster Title Theme Paper Number Oral time Session
Andrew Spencer APAC MRDR Oral Regional trends in first-line myeloma treatment: Real world results from the Australian & New Zealand and Asia-Pacific Myeloma and Related Diseases Registries HSANZ - Myeloma 138 Mon, Oct 27, 9:30 AM - 9:45 AM
HSANZ Free Communications 2: Myeloma Therapeutics
Ghassan Zammar ANZ MRDR Oral Cytogenetic testing in newly diagnosed multiple myeloma (NDMM): Real-world evidence of adverse outcomes for high-risk groups HSANZ - Myeloma 713 Tues, Oct 28, 9:45 AM - 10:00 AM
HSANZ Free Communications: Myeloma: Basic science
Jian Li ANZ MRDR Oral New Zealand multiple myeloma patients demonstrate inferior outcomes compared to Australian counterparts – a retrospective cohort study from the Myeloma and Related Diseases Registry
HSANZ - Myeloma
  Mon, Oct 27, 9:45 AM - 10:00 AM
HSANZ Free Communications 2: Myeloma Therapeutics
Sarah Zhao ANZ MRDR Oral First-line VRd, Rd, and VCd in elderly myeloma patients: Comparison of outcomes using the ANZ Myeloma and Related Diseases Registry HSANZ - Myeloma 311 Mon, Oct 27, 9:15 AM - 9:30 AM
HSANZ Free Communications 2: Myeloma Therapeutics
Jessica Ling ANZ MRDR Poster Outcomes of patients with multiple myeloma post-BCMA directed treatment: an Australian perspective        
Adam Irving EpiMAP Poster Bortezomib, lenalidomide and dexamethasone versus pre-funding standard of care for newly diagnosed multiple myeloma: a post-market economic evaluation using registry data HSANZ - Myeloma 451